Novo Nordisk and AWS bring agentic AI into drug discovery

Novo Nordisk is expanding use of AWS AI tools across drug discovery, including AI agents for target identification, therapy design, and research workflows. AWS will become Novo Nordisk's preferred cloud provider and strategic AI partner. The companies created a co-innovation hub at Novo Nordisk's London office.